Chapters
Transcript
Why test the combination of Trodelvy and pembrolizumab? Previous efforts testing immunotherapy for HR+ breast cancer has shown disappointing results.
Related Presenters
Filipa Lynce, MD
Medical Oncology
View Profile
Related Videos
Phenotype, Specificity and Avidity of Antitumour CD8+ T Cells in Melanoma
Bladder Cancer Advances
New Treatments for Bladder Cancer Patients
Next Questions: Chronic Lymphocytic Leukemia
Dana-Farber Research Looks at Blood Test to Detect Cancer
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
Dental
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Otolaryngology
Pulmonology
Surgery
Urology
person Sign In / Create Account
